Looks like this event has already ended.
Check out upcoming events by this organizer, or organize your very own event.
Science Shaping Our World (SHOW) – Ongoing Seminar/Networking Series: Development of Gene Therapy for Single Gene DisordersMunevar & Associates, Inc./Harvard Catalyst Laboratory for Innovative Translational Technologies (HC‐LITT) and the Harvard Catalyst Central Laboratory (HCCL)Thursday, March 31, 2011 from 6:00 PM to 9:00 PM (EDT)Boston, MA |
|
Event Details
When: Thursday, March 31, 2011
From: 6:00 PM – 9:00 PM
Where: TMEC Walter Amphitheater
Harvard Medical School
260 Longwood Ave
Boston, Massachusetts 02115
Keynote Speaker: Terry Flotte, M.D
-
Celia and Isaac Haidak Distinguished Professor
-
Dean, Provost and Executive Deputy Chancellor University of Massachusetts Medical School
Register at: http://showmarch2011.eventbrite.com
Science Shaping Our World (SHOW) is an ongoing seminar and networking series that highlights cutting edge translational life science research and development. Our mission is to bring together a multidisciplinary audience spanning academia and industry where they can gain exposure and insight into the life science advancements changing our world. Further, we seek to promote active inter and cross-disciplinary dialogue and networking opportunities toward fostering the creation of relationships bridging bench to bedside.
March’s SHOW will focus on the development and application of gene therapy for the treatment of single gene disorders. The presentation will focus on efforts to direct gene therapy to target sites including recent phase 2 clinical trial results aimed at treating genetic emphysema due to alpha-1 antitrypsin deficiency.
Gene therapy based therapeutic strategies involve the insertion of functional genes into patients’ cells in order to replace a mutated or otherwise faulty gene. Alternatively, gene therapy can also involve directly correcting the mutations or modifying normal genes that may enable a viral infection or microbial pathogenicity. Gene therapy based therapeutics are still evolving but are rapidly developing into new advancements at the bench, opening doors for potential applications in the clinic.
Please join us for an excellent evening of science, technology, and networking. Event registration is free and required with event sign-in beginning at 6:00 PM at Harvard Medical School. Presentation and discussion will follow from 6:30 – 7:15 PM. Following the presentation, you are invited to join us for networking and further discussion with the speaker. Light food and refreshments will be provided.
SHOW is produced by Munevar & Associates, Inc. and hosted by the Harvard Catalyst Laboratory for Innovative Translational Technologies (HC‐LITT) and the Harvard Catalyst Central Laboratory (HCCL).
Harvard University, HC‐LITT, HCCL, and Harvard Catalyst do not endorse any company or product. The opinions expressed during this event are solely those of Munevar & Associates, Inc. and do not represent the views of Harvard Catalyst, HCLITT, HCCL, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health (http://catalyst.harvard.edu).
When & Where
TMEC Walter Amphitheater
Harvard Medical School
260 Longwood Ave
Boston,
MA 02115
Thursday, March 31, 2011 from 6:00 PM to 9:00 PM (EDT)
Add to my calendar
Organizer
Munevar & Associates, Inc./Harvard Catalyst Laboratory for Innovative Translational Technologies (HC‐LITT) and the Harvard Catalyst Central Laboratory (HCCL)
About Munevar & Associates, Inc.:
Munevar & Associates, Inc. is a life science technology development and commercialization solutions company. Our mission is to couple scientific and technological experience and expertise, with commercialization insight and perspective, toward the translation of novel life science centered innovations.
The company is comprised of an integrated, multidisciplinary team of scientists, engineers, and business professionals focused on supporting the advancement, development, and commercialization of cutting-edge products and services.
About the Harvard Catalyst Laboratory for Innovative Translational Technologies:
The Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT), originally created and located at the Harvard School of Dental Medicine, provides the Harvard research community (basic and clinical researchers) with early access to enabling leading-edge genomic and proteomic technologies.
An integral part of Harvard Catalyst, the HC-LITT accelerates the translation of laboratory research in therapeutics and diagnostics into the clinic. The laboratory's 'collaborative research model' is very distinct from the 'traditional core' centers.